Clinical Trial Update: Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women [Phase 2]

View source ↗

Summary

Phase 2 study assessing pharmacokinetic interactions between depot medroxyprogesterone acetate (DMPA) and lopinavir/ritonavir (LPV/r) in HIV-infected women; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Depo-Provera (medroxyprogesterone acetate)
• Kaletra (lopinavir)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-12-22